Monday, June 23, 2008

Comorbidity -- Tables & Footnotes

Figure caption

Figure 1 Path Model Examining the Direct and Indirect Influence of Sensory Amplification on Physical Functioning With Pain Intensity, Physical Symptoms, Fatigue, and Attention/Concentration Symptoms as Mediating Variables

Tables

Table 1. Sample Characteristics, Mean (Standard Deviation)
--------
Variable
--------
Age, years                               42.0 (8.8)
Pain duration, months                    87.9 (64.4)
Gender                                    28 (73.6%) women, 10 (26.4%) men
Race                                      24 (63.2%) Caucasian,
                                           5 (13.2%) African American,
                                           4 (10.5%) Hispanic,
                                           2 (5.3%)  Asian or Pacific Islander,
                                           3 (7.9%) other
McGill Pain Questionnaire (MPQ) Total     11.3 (8.1)
Multidimensional Fatigue Inventory (MFI): 16.6 (2.7)
  General Fatigue
Number of physical symptoms               19.2 (9.7)
Multiple Random Staircase (MRS) medium     3.01 (2.1)
  pressure sensitivity (kg/cm^2)
Perceived exertion per watt                0.32 (0.11)
----------


Table 2. Correlations Among the Individual and Composite Measures of Sensory
         Augmentation and Depression, Hallmark Symptoms, Comorbid Fatigue, and
         Physical Functioning
--------
Variable              Pressure           Perceived Exertion      ISA
                      Sensitivity        per Watt
--------
Pain                  0.34*              0.45**                  0.45**
Fatigue               0.15              -0.16                   -0.01
Physical Functioning -0.36*             -0.20                   -0.32*
Depression            0.13               0.14                    0.16
Comorbidities         0.29               0.38*                   0.41*
--------
ISA: index of sensory amplification.
*p<0.05; **p<0.01.


Table 3. Correlations Between Sensory Augmentation, Depression, Hallmark Symptoms,
         Comorbid Physical Symptoms, and Physical Functioning
--------
Variable              Pain      Fatigue  Comorbidities    Physical     Depressive
                                                          Functioning  Symptoms
--------
ISA                   0.45**   -0.01     0.41*           -0.32*        0.16
Pain                            0.12     0.34*           -0.57**       0.22
Fatigue                                  0.02            -0.41*        0.34*
Comorbidities                                            -0.41*        0.08
Physical Functioning                                                   0.07
--------
ISA: index of sensory amplification.
*p<0.05; **p<0.01.


References

1. Fukuda K, Straus SE, Hickie I, et al, and the International Chronic
    Fatigue Syndrome Study Group: The chronic fatigue syndrome: a
    comprehensive approach to its definition and study. Ann Intern
    Med 1994; 121:953-959
2. Wolfe FW, Smythe HA, Yunus MB, et al: The American College
    of Rheumatology 1990 Criteria for the Classification of Fibro-
    myalgia. Arthritis Rheum 1990; 33:160-172
3. Yunus MB: Symptoms and signs of fibromyalgia syndrome: an
    overview, in Fibromyalgia and Other Central Pain Syndromes. Ed-
    ited by Wallace DJ, Clauw DJ. Philadelphia, PA, Lippincott, Wil-
    liams & Wilkins, 2005, pp 125-132
4. Katon W, Sullivan M, Walker E: Medical symptoms without iden-
    tified pathology: relationship to psychiatric disorders, childhood
    and adult trauma, and personality traits. Ann Intern Med 2001;
    134:917-925
5. Clauw DJ: The pathogenesis of chronic pain and fatigue syn-
    dromes, with special reference to fibromyalgia. Med Hypotheses
    1995; 44:369-378
6. Clauw DJ, Chrousos GP: Chronic pain and fatigue syndromes:
    overlapping clinical and neuroendocrine features and potential
    pathogenic mechanisms. Neuroimmunomodulation 1997; 4:134-153
7. Carrillo-de-la-Pen~na MT, Vallet M, Pe´rez MI, et al: Intensity de-
    pendence of auditory-evoked cortical potentials in fibromyalgia
    patients: a test of the generalized hypervigilance hypothesis. J Pain
    2006; 7:480-487
8. Lorenz J, Grasedyck K, Bromm B: Middle- and long-latency so-
    matosensory evoked potentials after painful laser stimulation in
    patients with fibromyalgia syndrome. EEG Clin Neurophysiol
    1996; 100:165-168
9. McDermid AJ, Rollman GB, McCain GA: Generalized hypervi-
    gilance in fibromyalgia: evidence of perceptual amplification. Pain
    1996; 66:133-144
10. Ozgocman S, Yoldas T, Kamanli A, et al: Auditory P300 event-
    related potentials and serotonin reuptake inhibitor treatment in pa-
    tients with fibromyalgia. Ann Rheum Dis 2003; 62:551-555
11. Montoya P, Sitges C, Garcia-Herrera M, et al: Reduced brain ha-
    bituation to somatosensory stimulation in patients with fibro-
    myalgia. Arthritis Rheum 2006; 54:1995-2003
12. Geisser ME, Casey KL, Brucksch CB, et al: Perception of noxious
    and innocuous heat stimulation among healthy women and women
    with fibromyalgia: association with mood, somatic focus, and ca-
    tastrophizing. Pain 2003; 102:243-250
13. Lautenbacher S, Rollman GB, McCain GA: Multi-method assess-
    ment of experimental and clinical pain in patients with fibro-
    myalgia. Pain 1994; 59:45-53
14. Fields H: Depression and pain: a neurobiological model. Neuro-
    psychiatry Neuropsychol Behav Neurol 1991; 4:83-92
15. Giesicke T, Gracely RH, Williams DA, et al: The relationship be-
   tween depression, clinical pain, and experimental pain in a
    chronic-pain cohort. Arthritis Rheum 2005; 52:1577-1584
16. Sayar K, Barsky AJ, Gulec H: Does somatosensory amplification
    decrease with antidepressant treatment? Psychosomatics 2005;
    46:340-344
17. Wolfe F, Hawley DJ: Evidence of disordered symptom appraisal
    in fibromyalgia: increased rates of reported comorbidity and co-
    morbidity severity. Clin Exp Rheumatol 1999; 17:297-303
18. Bennett RM, Schein J, Kosinski MR, et al: Impact of fibro-
    myalgia pain on health-related quality of life before and after
    treatment with tramadol/acetaminophen. Arthritis Rheum 2005;
    53:519-527
19. Bergman S: Psychosocial aspects of chronic widespread pain and
    fibromyalgia. Disabil Rehabil 2005; 27:675-683
20. Reeves WC, Wagner D, Nisenbaum R, et al: Chronic fatigue syn-
    drome: a clinically empirical approach to its definition and study.
    BMC Med 2005; 3:19
21. Melzack R: The Short-Form McGill Pain Questionnaire. Pain
    1987; 30:191-197
22. Radloff L: The CES­D scale: a self-report depression scale for
    research in the general population. Appl Psychol Meas 1977;
    1:385-401
23. Berkman LF, Berkman CS, Kasl S, et al: Depressive symptoms in
    relation to physical health and functioning in the elderly. Am J
    Epidemiol 1986; 124:372-388
24. Geisser ME, Roth RS, Robinson ME: Assessing depression among
    persons with chronic pain, using the Center for Epidemiological
    Studies - Depression scale and the Beck Depression Inventory: a
    comparative analysis. Clin J Pain 1997; 13:163-170
25. Turk DC, Okifuji A: Detecting depression in chronic pain patients:
    adequacy of self-reports. Behav Res Ther 1994; 32:9-16
26. Smets EM, Garssen B, Bonke B, et al: The Multidimensional Fa-
    tigue Inventory (MFI): psychometric qualities of an instrument to
    assess fatigue. J Psychosom Res 1995; 39:315-325
27. Ware JE Jr: SF-36 Health Survey update. Spine 2000; 25:3130-3139
28. Ware JE Jr: Using generic measures of functional health and well-
    being to increase understanding of disease burden. Spine 2000;
    25:1467
29. Petzke F, Khine A, Williams D, et al: Dolorimetry performed at
    three paired tender points highly predicts overall tenderness. J
    Rheumatol 2001; 28:2568-2569
30. Gracely RH, Lota L, Walter DJ, et al: A multiple random staircase
    method of psychophysical pain assessment. Pain 1988; 32:55-63
31. Gracely RH, Dubner R, McGrath PA: Narcotic analgesia: fentanyl
    reduces the intensity but not the unpleasantness of painful tooth
    pulp sensations. Science 1979; 203:1261-1263
32. Borg G: Perceived exertion as an indicator of somatic stress. Scand
    J Rehabil Med 1970; 2:92-98
33. Lyden AK, Williams DA, Groner K, et al: Processing of sensory
    sensations associated with exercise and experimental pain in fi-
    bromyalgia. J Pain 2004; 5(3; suppl 1):37
34. Kerlinger FN, Pedhazer EJ: Multiple Regression in Behavioral
    Research: Explanation and Prediction. New York, Holt, Rinehart,
    and Winston, Inc, 1973, pp 281-333
35. Heim C, Wagner D, Maloney E, et al: Early adverse experience
    and risk for chronic fatigue syndrome: results from a population-
    based study. Arch Gen Psychiatry 2006; 63:1258-1266
36. Peters ML, Vlaeyen JWS, van Drunen C: Do fibromyalgia patients
    display hypervigilance for innocuous somatosensory stimuli? ap-
    plication of a body-scanning reaction time paradigm. Pain 2000;
    86:283-292
37. Giesecke T, Gracely RH, Grant MAB, et al: Evidence of aug-
    mented central pain processing in idiopathic chronic low back
    pain. Arthritis Rheum 2004; 50:613-623
38. Gracely RH, Petzke F, Park K, et al: Functional MRI evidence of
    augmented pain processing in fibromyalgia, Arthritis Rheum
    2002; 46:1333-1343
39. Craig AD: Interoception: the sense of the physiological condition
    of the body. Curr Opin Neurol 2003; 13:500-505
40. Critchley HD, Wiens S, Rotshtein P, et al: Neural systems sup-
    porting interoceptive awareness. Nat Neurosci 2004; 7:189-195
41. Cook DB, Nagelkirk PR, Poluri A, et al: The influence of aerobic
    fitness and fibromyalgia on cardiorespiratory and perceptual re-
    sponses to exercise in patients with chronic fatigue syndrome. Ar-
    thritis Rheum 2006; 54:3351-3362

--------
(c) 2008 American Psychiatric Publishing
         The Academy of Psychosomatic Medicine

No comments: